VeriChip


Also found in: Dictionary, Wikipedia.
Related to VeriChip: Rfid

VeriChip

A tiny, glass-encased RFID chip from PositiveID Corporation, Delray Beach, FL (www.positiveidcorp.com) that is injected with a special syringe under a person's skin in an outpatient procedure. When scanned, the unique ID number in the RFID chip is used to link to an identification database for security purposes or for medical information. In 2004, the VeriChip was approved by the U.S. Food and Drug Administration.

Very Controversial
A counterpart HomeAgain chip from the company was also used for animals, but studies showed that some of them developed cancer around the implant. In addition, citing biblical Scripture (Revelation 13:16-18), people voiced extreme opposition to "chipping" humans.

What Happened?
Originally developed by a division of Digital Angel Corporation, the company merged with PositiveID Corporation in 2010. In 2011, VeriChip was sold to VeriTeQ Acquisition, owned by PositiveID's CEO, who had recently stepped down. In 2012, VeriTeQ merged with Connectyx Technologies, which offers the MedFlash health records system. MedFlash uses ID cards with QR codes and USB drives for identification, and RFID implants are not mentioned on the Connectyx website. See RFID and microchip implant.
References in periodicals archive ?
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets.
My objection to the VeriChip, however, is that I don't see what is gained by placing the chip in my arm as opposed to giving me a bracelet with an RFID tag, like a medical alert bracelet.
The VeriChip can also be read by scanners on buildings to identify people coming or going.
The VeriChip is an implant the size of a rice grain manufactured by Applied Digital Solutions of Delray Beach, Fla.
As with many federal proposals--from creation of a Homeland Security department to the war on Iraq--introduction of the VeriChip is being piggybacked on the 9/11 tragedy as a way of gaining mainstream acceptance.
We believe that our VeriChip patient identification microchip as well as our products under development, including a glucose-sensing RFID microchip and a rapid virus detection system for the H1N1 virus and other forms of influenza, are products that can improve the standard of healthcare and therefore the lives of patients.
As hospital maternity wards and long-term care centers continue to adopt radio frequency-based solutions, VeriChip Corporation, as the leader in this market, is well positioned to continue its growth.
For now, the VeriChip will be limited to holding only a unique identification number that can be cross-referenced to Applied Digital's Global VeriChip Subscriber Registry database, set to launch on May 1, 2002.
April 12 /PRNewswire/ -- VeriChip announced today that it has appointed Jonathan Musher, MD, CMD Chief Medical Officer and Vice President, Medical Affairs.
Dan Gunther, president of VeriChip, commented, "We applaud the proactive approach to infant protection taken by so many hospitals in Puerto Rico, and we are proud to partner with these hospitals to help protect their smallest patients.
amp; MIAMI -- VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) announced today that it has entered into a strategic partnership with the Diabetes Research Institute ("DRI") to combine efforts on the further development of the glucose-sensing radio frequency identification (RFID) microchip in conjunction with VeriChip's development partner, RECEPTORS LLC.
March 29 /PRNewswire-FirstCall/ -- VeriChip Corporation , a provider of RFID systems for healthcare and patient-related needs, will present at the American Medical Directors Association (AMDA) 30th Annual Symposium in Hollywood, Florida, on March 29- 30, 2007.